Boundless Bio
Latest round
- Series C
Last raised
- May 2023
Total raised
- $228M
Investors
- 17
About Boundless Bio
Founded in 2019 and headquartered in San Diego, US, Boundless Bio, Inc. is dedicated to developing next-generation oncology therapies.Boundless Bio specializes in developing next-generation precision oncology therapies, particularly ecDNA-directed therapies (ecDTx) that target oncogene amplified cancers characterized by extrachromosomal DNA (ecDNA). Using the proprietary Spyglass platform, Boundless Bio identifies vulnerabilities in cancer cells reliant on ecDNA, enabling the design of therapies specifically targeting these weaknesses.14 mn.Following a successful IPO on March 27, 2024, where Boundless Bio, Inc. As Boundless Bio continues to innovate in the oncology sector, they plan to target new geographic markets, enhancing access to their therapeutic offerings in regions where oncogene amplified cancers are prevalent.
Who invested in Boundless Bio
17 investors across 3 rounds
See all investors in Boundless Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Boundless Bio
Who invested in Boundless Bio?
Boundless Bio has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Boundless Bio raised?
Boundless Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Boundless Bio last raise money?
Boundless Bio's most recent round on record is a Series C, in May 2023.
What does Boundless Bio do?
Founded in 2019 and headquartered in San Diego, US, Boundless Bio, Inc.
Where is Boundless Bio headquartered?
Boundless Bio is headquartered in San Diego, US.
Which VCs invest in companies like Boundless Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Boundless Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Boundless Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.